These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 9799243)

  • 1. Phosphorylation-dephosphorylation differentially affects activities of splicing factor ASF/SF2.
    Xiao SH; Manley JL
    EMBO J; 1998 Nov; 17(21):6359-67. PubMed ID: 9799243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Both phosphorylation and dephosphorylation of ASF/SF2 are required for pre-mRNA splicing in vitro.
    Cao W; Jamison SF; Garcia-Blanco MA
    RNA; 1997 Dec; 3(12):1456-67. PubMed ID: 9404896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A serine/arginine-rich domain in the human U1 70k protein is necessary and sufficient for ASF/SF2 binding.
    Cao W; Garcia-Blanco MA
    J Biol Chem; 1998 Aug; 273(32):20629-35. PubMed ID: 9685421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The splicing factor-associated protein, p32, regulates RNA splicing by inhibiting ASF/SF2 RNA binding and phosphorylation.
    Petersen-Mahrt SK; Estmer C; Ohrmalm C; Matthews DA; Russell WC; Akusjärvi G
    EMBO J; 1999 Feb; 18(4):1014-24. PubMed ID: 10022843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation of the ASF/SF2 RS domain affects both protein-protein and protein-RNA interactions and is necessary for splicing.
    Xiao SH; Manley JL
    Genes Dev; 1997 Feb; 11(3):334-44. PubMed ID: 9030686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SF2/ASF binds to a splicing enhancer in the third HIV-1 tat exon and stimulates U2AF binding independently of the RS domain.
    Tange TØ; Kjems J
    J Mol Biol; 2001 Sep; 312(4):649-62. PubMed ID: 11575921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific inhibition of serine- and arginine-rich splicing factors phosphorylation, spliceosome assembly, and splicing by the antitumor drug NB-506.
    Pilch B; Allemand E; Facompré M; Bailly C; Riou JF; Soret J; Tazi J
    Cancer Res; 2001 Sep; 61(18):6876-84. PubMed ID: 11559564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic analysis of the SR protein ASF/SF2: interchangeability of RS domains and negative control of splicing.
    Wang J; Xiao SH; Manley JL
    Genes Dev; 1998 Jul; 12(14):2222-33. PubMed ID: 9679066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulated tissue-specific expression of antagonistic pre-mRNA splicing factors.
    Hanamura A; Cáceres JF; Mayeda A; Franza BR; Krainer AR
    RNA; 1998 Apr; 4(4):430-44. PubMed ID: 9630249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of the SR proteins 9G8, SC35, ASF/SF2, and SRp40 on the utilization of the A1 to A5 splicing sites of HIV-1 RNA.
    Ropers D; Ayadi L; Gattoni R; Jacquenet S; Damier L; Branlant C; Stévenin J
    J Biol Chem; 2004 Jul; 279(29):29963-73. PubMed ID: 15123677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of SRp20 exon 4 splicing.
    Jumaa H; Nielsen PJ
    Biochim Biophys Acta; 2000 Nov; 1494(1-2):137-43. PubMed ID: 11072076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-mRNA splicing in the absence of an SR protein RS domain.
    Zhu J; Krainer AR
    Genes Dev; 2000 Dec; 14(24):3166-78. PubMed ID: 11124808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific interactions between proteins implicated in splice site selection and regulated alternative splicing.
    Wu JY; Maniatis T
    Cell; 1993 Dec; 75(6):1061-70. PubMed ID: 8261509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion of the N-terminus of SF2/ASF permits RS-domain-independent pre-mRNA splicing.
    Shaw SD; Chakrabarti S; Ghosh G; Krainer AR
    PLoS One; 2007 Sep; 2(9):e854. PubMed ID: 17786225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exon identity established through differential antagonism between exonic splicing silencer-bound hnRNP A1 and enhancer-bound SR proteins.
    Zhu J; Mayeda A; Krainer AR
    Mol Cell; 2001 Dec; 8(6):1351-61. PubMed ID: 11779509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substrate specificities of SR proteins in constitutive splicing are determined by their RNA recognition motifs and composite pre-mRNA exonic elements.
    Mayeda A; Screaton GR; Chandler SD; Fu XD; Krainer AR
    Mol Cell Biol; 1999 Mar; 19(3):1853-63. PubMed ID: 10022872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of a PKCI-1-related mRNA is controlled by the splicing factor ASF/SF2: a novel function for SR proteins.
    Lemaire R; Prasad J; Kashima T; Gustafson J; Manley JL; Lafyatis R
    Genes Dev; 2002 Mar; 16(5):594-607. PubMed ID: 11877379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of dephosphorylation of the SR protein ASF/SF2 by protein phosphatase 1.
    Ma CT; Ghosh G; Fu XD; Adams JA
    J Mol Biol; 2010 Oct; 403(3):386-404. PubMed ID: 20826166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of essential splicing factor ASF/SF2 blocks the temporal shift in adenovirus pre-mRNA splicing and reduces virus progeny formation.
    Molin M; Akusjärvi G
    J Virol; 2000 Oct; 74(19):9002-9. PubMed ID: 10982344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylation status of the Kep1 protein alters its affinity for its protein binding partner alternative splicing factor ASF/SF2.
    Robard C; Daviau A; Di Fruscio M
    Biochem J; 2006 Nov; 400(1):91-7. PubMed ID: 16834570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.